Empagliflozin Sheds Liver Fat in People With and Without T2D
Empagliflozin reduced liver fat content in patients with obesity and patients with type 2 diabetes.
Medscape Medical News
source https://www.medscape.com/viewarticle/empagliflozin-sheds-liver-fat-people-and-without-t2d-2024a10003ie?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/empagliflozin-sheds-liver-fat-people-and-without-t2d-2024a10003ie?src=rss
Comments
Post a Comment